iwNHL 2015: Ibrutinib, Bruton’s tyrosine kinase inhibitor, for non-Hodgkin lymphoma

At the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting, Thomas J. Kipps, MD, PhD, of the University of California, San Diego, San Diego, CA, discusses the currently available data ... Author: VJHemOnc Added: 11/22/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts